Activated microglia produce superoxide anion (O-2(center dot-)) and nitric oxide (NO), both of which can be neurotoxic. To identify regulatory mechanisms that might modulate over-activation of microglia, we evaluated the inhibition of microglial activation by factors secreted by hippocampal cells. Supernatants from hippocampal cell cultures (Hippocampal-Cm) prevented microglial O-2(center dot) and NO production. LAP-TGF beta 1 was present in the Hippocampal-Cm as shown by immunoblot and a TGF beta 1-dependent proliferation-inhibition bioassay. LAP-TGF beta 1 and TGF beta activity increased in hippocampal cultures exposed to proinflammatory conditions (LPS and Interferon-gamma). The inhibition of (O-2(center dot-)) and NO production by Hippocampal-Cm was mimicked by the addition of recombinant TGF beta 1. Treating Hippocampal-Cm with an antibody against TGF beta 1 to neutralize its activity eliminated its ability to inhibit O-2(center dot-) and NO production. Our findings suggest that the TGF beta 1 secreted by hippocampal cells modulated microglial activity. We propose that in pathological conditions, impairment of this modulatory mechanism could enhance microglia-mediated neurotoxicity. (c) 2005 Elsevier Inc. All rights reserved.
Registro Sencillo
Registro Completo
Autor | Herrera Molina, R von Bernhardi, R |
Título | Transforming growth factor-beta 1 produced by hippocampal cells modulates microglial reactivity in culture |
Revista | NEUROBIOLOGY OF DISEASE |
ISSN | 0969-9961 |
ISSN electrónico | 1095-953X |
Volumen | 19 |
Número de publicación | 1-2 |
Página inicio | 229 |
Página final | 236 |
Fecha de publicación | 2005 |
Resumen | Activated microglia produce superoxide anion (O-2(center dot-)) and nitric oxide (NO), both of which can be neurotoxic. To identify regulatory mechanisms that might modulate over-activation of microglia, we evaluated the inhibition of microglial activation by factors secreted by hippocampal cells. Supernatants from hippocampal cell cultures (Hippocampal-Cm) prevented microglial O-2(center dot) and NO production. LAP-TGF beta 1 was present in the Hippocampal-Cm as shown by immunoblot and a TGF beta 1-dependent proliferation-inhibition bioassay. LAP-TGF beta 1 and TGF beta activity increased in hippocampal cultures exposed to proinflammatory conditions (LPS and Interferon-gamma). The inhibition of (O-2(center dot-)) and NO production by Hippocampal-Cm was mimicked by the addition of recombinant TGF beta 1. Treating Hippocampal-Cm with an antibody against TGF beta 1 to neutralize its activity eliminated its ability to inhibit O-2(center dot-) and NO production. Our findings suggest that the TGF beta 1 secreted by hippocampal cells modulated microglial activity. We propose that in pathological conditions, impairment of this modulatory mechanism could enhance microglia-mediated neurotoxicity. (c) 2005 Elsevier Inc. All rights reserved. |
Derechos | acceso restringido |
DOI | 10.1016/j.nbd.2005.01.003 |
Editorial | ACADEMIC PRESS INC ELSEVIER SCIENCE |
Enlace | |
Id de publicación en Pubmed | MEDLINE:15837578 |
Id de publicación en WoS | WOS:000228672900024 |
Paginación | 8 páginas |
Palabra clave | cytokines hippocampal cell inflammation microglial cells neurodegeneration nitric oxide superoxide anion TGF beta 1 NITRIC-OXIDE SYNTHASE INFLAMMATORY RESPONSE TGF-BETA OXIDATIVE STRESS BRAIN-INJURY IFN-GAMMA NEURONS ACTIVATION EXPRESSION TGF-BETA-1 |
Tema ODS | 03 Good Health and Well-being |
Tema ODS español | 03 Salud y bienestar |
Tipo de documento | artículo |